Program Schedule

1782
New TB Drugs in the Pipeline

Session: Symposium: New Issues in HIV-Related Opportunistic Infection Management
Saturday, October 11, 2014: 2:00 PM
Room: The Pennsylvania Convention Center: 118-ABC
Eric Nuermberger, MD, Medicine, Johns Hopkins University, Baltimore, MD

Dr. Nuermberger received his MD degree from Vanderbilt University Medical School in 1996. He completed his residency in Internal Medicine (1999) and fellowship in Infectious Diseases (2003) at Johns Hopkins Hospital. From 2000-2001, he served as Assistant Chief of Service in the Department of Medicine. He joined the faculty of the Division of Infectious Diseases as an Assistant Professor in 2003. In addition to his activities in clinical care, teaching and research, he serves on the Antibiotic Subcommittee of the Pharmacy and Therapeutics Committee for the hospital.
Dr. Nuermberger’s research interests are pre-clinical development of new drugs for tuberculosis and the pharmacokinetics and pharmacodynamics of antimicrobial therapy. He is an Associate Editor for Antimicrobial Agents and Chemotherapy and The International Journal of Tuberculosis and Lung Disease. He has received research support from the National Institutes of Health, the Bill and Melinda Gates Foundation, the Global Alliance for TB Drug Development and pharmaceutical companies.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek